November 19, 2026

ECHA Proposes OEL for Copper in Draft Evaluation

The European Chemicals Agency (ECHA) has released a draft of its evaluation of occupational limit values for copper and its inorganic compounds. The draft report is intended for consideration by ECHA’s Committee for Risk Assessment (RAC) as it prepares its opinion on the substances.

The draft report recommends eight-hour, time-weighted average (TWA) occupational exposure limits of 0.01 mg/m3 for the respirable fraction and 0.1 mg/m3 for the inhalable fraction of copper and its inorganic compounds. In the United States, the OSHA permissible exposure limit for copper fume and copper oxide is 0.1 mg/m3 as an eight-hour TWA, and the NIOSH recommended exposure limit is 0.1 mg/m3 for a TWA of up to 10 hours. ECHA also recommends a biological guidance value of 60 µg/L in urine. The agency is not proposing a short-term exposure limit.

The evaluation applies to copper, copper oxide, dicopper oxide, copper chloride, and copper sulphate, which together encompass more than 99 percent of the total estimated tonnage of copper compounds used in the European Union, the report states. A total of 45 copper compounds are registered under the EU’s Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulation.

Copper is used as wiring and plumbing in construction and as a conductive/plating agent in infrastructure for power grids and the telecom industry. The copper compounds discussed in the report are also used in plating and in pigments and dyes, fertilizers, catalysts, and lab reagents.

Copper exposure can cause respiratory irritation, nausea, and metal fume fever. Some studies have reported respiratory symptoms, impaired lung function, and radiographic abnormalities from welding and secondary copper smelting, although exposure to other metals complicate the relationship, according to ECHA. “Substantial uncertainty remains on the relationship between inhaled copper exposure and chronic respiratory effects due to co-exposures, exposure-assessment limitations, and differences in study populations and designs,” the report states.

The report indicates that limited or unclear evidence exist on the relationship between copper exposure and Alzheimer’s disease or cognitive decline. Similarly, studies in humans present “limited and inconsistent” evidence for the genotoxicity of copper, although most animal studies were positive for genotoxicity, the report states. A causal relationship between exposure and carcinogenicity has not been established.

According to the report, REACH data indicate that exposures in copper manufacturing can be as high as 1 mg/m3 during activities like smelting, handling of raw material and scrap, and other tasks. Many of these tasks involve melting and inhaling the fumes, or manual handling of powders and flakes, typically in unenclosed spaces that rely on local exhaust ventilation or respirators to protect workers. Other tasks, such as etching and making alloys, are more enclosed or automated, with worker exposures typically around 0.01 mg/m3, the report states.

From the ECHA website, interested parties can download the draft report and submit comments to the agency. Comments are due by Dec. 14.